« US to ask if Sanofi antibiotic Ketek should still be sold | Main | FDA seeks outside review of Ketek antibiotic on December 14 and 15 »

Ketek Labeling to Include Strong Liver Warning

The FDA and Sanofi-Aventis, the makers of Ketek, have announced that Ketek’s labeling will now include a strong warning about serious and potentially fatal Ketek liver side effects and other serious injuries. While developing serious Ketek side effects is rare, dozens of people have been seriously injured because of this medication. (Source)

Posted by Michael Monheit on November 20, 2006 10:44 AM |

TrackBack

TrackBack URL for this entry:
http://blogs.legalview.com/mt-admin/mt-tb.cgi/639

Post a comment

(If you haven't left a comment here before, you may need to be approved by the site owner before your comment will appear. Until then, it won't appear on the entry. Thanks for waiting.)